The role of neuraminidase 1 and 2 in glycoprotein Ibα-mediated integrin αIIbβ3 activation.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
04 2020
Historique:
received: 01 01 2019
accepted: 03 07 2019
pubmed: 6 7 2019
medline: 28 4 2021
entrez: 6 7 2019
Statut: ppublish

Résumé

Upon vascular injury, platelets adhere to von Willebrand Factor (VWF)

Identifiants

pubmed: 31273092
pii: haematol.2019.215830
doi: 10.3324/haematol.2019.215830
pmc: PMC7109719
doi:

Substances chimiques

Platelet Glycoprotein GPIIb-IIIa Complex 0
Platelet Glycoprotein GPIb-IX Complex 0
von Willebrand Factor 0
NEU1 protein, human EC 3.2.1.18
NEU2 protein, human EC 3.2.1.18
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1081-1094

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

Haematologica. 2013 Jul;98(7):e70-2
pubmed: 23716547
Nouv Rev Fr Hematol. 1985;27(4):211-7
pubmed: 2997701
Anal Biochem. 1979 Apr 15;94(2):287-96
pubmed: 464297
Thromb Res. 1979;14(4-5):697-704
pubmed: 483264
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16143-8
pubmed: 22988088
J Biol Chem. 2006 Sep 15;281(37):27526-38
pubmed: 16835219
J Clin Invest. 1978 Aug;62(2):496-9
pubmed: 307560
J Biol Chem. 2001 Jul 6;276(27):25121-6
pubmed: 11352922
Blood. 2016 Oct 13;128(15):1959-1968
pubmed: 27554083
Cell. 2003 Jan 10;112(1):87-97
pubmed: 12526796
Haematologica. 2012 Dec;97(12):1873-81
pubmed: 22733027
Thromb Res. 2000 Apr 1;98(1):51-7
pubmed: 10706933
Thromb Haemost. 2010 May;103(5):1033-43
pubmed: 20216992
Sci Rep. 2016 Dec 05;6:38363
pubmed: 27917893
Adv Carbohydr Chem Biochem. 2010;64:403-79
pubmed: 20837202
Biochem J. 2006 Mar 15;394(Pt 3):647-56
pubmed: 16241905
J Cell Biol. 1972 Oct;55(1):147-60
pubmed: 4653414
Haematologica. 2012 Oct;97(10):1514-22
pubmed: 22371179
J Biol Chem. 2011 Oct 21;286(42):36532-49
pubmed: 21873432
J Clin Invest. 1985 Jan;75(1):19-25
pubmed: 2981249
Blood Adv. 2017 Feb 23;1(7):429-442
pubmed: 29296958
J Thromb Haemost. 2016 Dec;14(12):2446-2457
pubmed: 27732771
Blood. 2012 Jul 5;120(1):214-22
pubmed: 22517896
J Biol Chem. 1990 Oct 25;265(30):18531-7
pubmed: 2211717
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8360-8365
pubmed: 28716912
Science. 2003 Jul 11;301(5630):218-21
pubmed: 12855810
Nat Commun. 2015 Jul 17;6:7737
pubmed: 26185093
Br J Haematol. 1974 Apr;26(4):645-50
pubmed: 4546443
J Biol Chem. 2004 Aug 27;279(35):37021-9
pubmed: 15213228
Blood. 2001 Sep 15;98(6):1955-62
pubmed: 11535535
J Biol Chem. 1983 May 25;258(10):6335-9
pubmed: 6406478
Infect Immun. 2018 Sep 21;86(10):
pubmed: 30037798
J Thromb Haemost. 2010 Feb;8(2):341-50
pubmed: 19840363
FEBS Lett. 1975 Feb 1;50(2):269-71
pubmed: 1112418
Blood. 2010 Aug 19;116(7):1157-64
pubmed: 20457869
Blood. 2005 Oct 15;106(8):2750-6
pubmed: 15985541
Thromb Haemost. 1980 Feb 29;42(5):1673-8
pubmed: 7368163
Genes Dev. 1996 Dec 15;10(24):3156-69
pubmed: 8985184
FEBS Lett. 1993 Aug 9;328(1-2):30-4
pubmed: 7688323
Blood. 2012 Feb 2;119(5):1263-73
pubmed: 22101895
J Biol Chem. 1978 Oct 25;253(20):7202-6
pubmed: 100492
Mol Cells. 2004 Apr 30;17(2):267-73
pubmed: 15179041
FEBS Lett. 1988 Feb 15;228(2):321-6
pubmed: 3342888
Science. 2003 Sep 12;301(5639):1531-4
pubmed: 12970565
Antimicrob Agents Chemother. 2008 Oct;52(10):3484-91
pubmed: 18694948
Curr Opin Hematol. 2010 Nov;17(6):585-9
pubmed: 20729731
Blood. 2019 Apr 4;133(14):1585-1596
pubmed: 30770394
Haematologica. 2013 Nov;98(11):1810-8
pubmed: 23753027
Oncogene. 2009 Mar 5;28(9):1218-29
pubmed: 19151752
Dev Cell. 2008 Jul;15(1):74-86
pubmed: 18606142
Thromb Res. 1982 Aug 15;27(4):397-403
pubmed: 7147211
Arterioscler Thromb Vasc Biol. 2017 Dec;37(12):2271-2279
pubmed: 29097365
Biochim Biophys Acta. 1972 Oct 25;279(3):456-74
pubmed: 5082512
Nat Commun. 2016 Sep 27;7:12863
pubmed: 27670775
J Thromb Haemost. 2010 Nov;8(11):2554-62
pubmed: 20735720
Thromb Res. 2000 Jul 15;99(2):165-72
pubmed: 10946090
Proteins. 2012 Apr;80(4):1123-32
pubmed: 22228546

Auteurs

Dianne E van der Wal (DE)

Australian Red Cross Lifeblood (formerly known as Blood Service) divanderwal@redcrossblood.org.au.

April M Davis (AM)

Australian Red Cross Lifeblood (formerly known as Blood Service).

Melanie Mach (M)

Australian Red Cross Lifeblood (formerly known as Blood Service).

Denese C Marks (DC)

Australian Red Cross Lifeblood (formerly known as Blood Service).
Sydney Medical School, Uinversity of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH